HealthcareAscendis raised to outperform by Oppenheimer ahead of drug launchBy Helitra.com·September 7, 2024·1 min read Ascendis raised to outperform by Oppenheimer ahead of drug launch Source: SeekingalphaADVERTISEMENT ADVERTISEMENTahead Ascendis drug launch Oppenheimer outperform raised Post navigation Previous storyVor Bio stock rallies post-market on trem-cel study dataNext storyLisata jumps on FDA orphan drug status for liver cancer drug
Fitness · HealthcareOzempic may reduce oxygen supply to developing fetuses, animal study findsNovember 13, 2026Researchers set out to check the safety of using weight loss jabs during pregnancy, and came across a worrying finding in their animal-based…
Fitness · HealthcareDoctor Explains Jennifer Lawrence’s Postpartum ClaimNovember 13, 2026Of all the things people warn you about childbirth, the fate of your butthole isn’t usually at the top of the list. Jennifer…
Fitness · HealthcareRisk of pregnancy loss tied to common antibiotic for acne and infectionsNovember 13, 2026When you buy through links on our articles, Future and its syndication partners may earn a commission. The antibiotic doxycycline is commonly prescribed…